Skip to content

DELAPHARMA

Active Risk: not assessed
Private limited companyfounded 200421 yrs activeGrote Markt(D) 4, 8600 Diksmuide, BelgiumKBO/BCE: BE 0867.801.095
Summary

DELAPHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.3m and a net result of -€93,278. Equity is growing by ~13% per year across the filed fiscal years. Its solvency ranks better than 36% of 5565 sector peers (fiscal year 2025). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 01-04-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 d early
2024
on the day
2023
1 d early
2022
3 d early
2021
4 d early
2020
45 d early
2019
31 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 16 days before the deadline; the sector median for financial year 2024 is 14 days before the deadline, and 28% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
27-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 13 October 2004, DELAPHARMA was incorporated.1 Total assets went from EUR 755,798 in 2018 to EUR 3.5 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€1.3m▼ 6.9%
2024 · €1.3m
Net result
-€93,278
2024 · €341,359
Total assets
€3.5m▲ 3.8%
2024 · €3.4m
Solvency
35.8%▼ 4.1pp
2024 · 39.9%
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€34,542▼ 64.9%€28,626▼ 17.1%€22,150▼ 22.6%-€165,203-€89,027▲ 46.1%
Net result€377,331above the sector's middle half▲ 465%€13,963within the sector's middle half▼ 96.3%€12,923within the sector's middle half▼ 7.4%€341,359above the sector's middle half▲ 2,541%-€93,278below the sector's middle half
Equity€978,076within the sector's middle half▲ 62.1%€992,039within the sector's middle half▲ 1.4%€1.0mwithin the sector's middle half▲ 1.3%€1.3mwithin the sector's middle half▲ 34.0%€1.3mwithin the sector's middle half▼ 6.9%
Total assets€1.6mwithin the sector's middle half▲ 114%€2.1mwithin the sector's middle half▲ 29.0%€2.7mwithin the sector's middle half▲ 26.4%€3.4mwithin the sector's middle half▲ 26.1%€3.5mwithin the sector's middle half▲ 3.8%
Debt€662,961▲ 305%€1.1m▲ 69.7%€1.7m▲ 48.6%€2.0m▲ 21.4%€2.3m▲ 10.9%
Working capital-€34,973▲ 29.7%-€354,223▼ 913%-€1.0m▼ 196%-€1.6m▼ 49.7%-€1.8m▼ 14.4%
Solvency59.6%within the sector's middle half▼ 19.0pp46.9%within the sector's middle half▼ 12.7pp37.5%within the sector's middle half▼ 9.3pp39.9%within the sector's middle half▲ 2.3pp35.8%within the sector's middle half▼ 4.1pp
above within below the middle half (P25 to P75) of NACE 64, Financial service activities, except insurance and pension funding, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
-€200,000€0€200,000€400,000Operating result 2021: €34,542€34,542Net result 2021: €377,331€377,331Operating result 2022: €28,626€28,626Net result 2022: €13,963€13,963Operating result 2023: €22,150€22,150Net result 2023: €12,923€12,923Operating result 2024: -€165,203-€165,203Net result 2024: €341,359€341,359Operating result 2025: -€89,027-€89,027Net result 2025: -€93,278-€93,27820212022202320242025-€200,000€0€200,000€400,000Operating result 2023: €22,150€22,200Net result 2023: €12,923€12,900Operating result 2024: -€165,203-€165,000Net result 2024: €341,359€341,000Operating result 2025: -€89,027-€89,000Net result 2025: -€93,278-€93,300202320242025
The operating result stays negative: a loss of €89,027 in 2025 against €165,203 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €3.5m
Fixed assets €3.4m ▲ 3.1%
Current assets €97,472 ▲ 39.4%
Equity and liabilities €3.5m
Equity €1.3m ▼ 6.9%
Debt €2.3m ▲ 10.9%
Debt's share of the balance-sheet total rises from 60.1% to 64.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
ROE
-7.4%▼
2024 · 25.4%
ROA
-2.7%▼
2024 · 10.1%
Debt ≤ 1 year
€1.9m▲
2024 · €1.6m
Debt > 1 year
€355,455▼
2024 · €387,636
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€3.4m€3.5m▲
Fixed assets21/28€3.3m€3.4m▲
Tangible fixed assets22/27€2.6m€2.7m▲
Land and buildings22€2.6m€2.6m▲
Plant, machinery and equipment23€4,994-
Furniture and vehicles24-€84,337
Financial fixed assets28€717,723€717,723=
Current assets29/58€69,934€97,472▲
Amounts receivable within one year40/41€37,892€20,125▼
Trade receivables40€30,250€15,125▼
Other amounts receivable41€7,642€5,000▼
Cash at bank and in hand54/58€31,278€76,136▲
Deferred charges and accrued income490/1€763€1,211▲
Equity and liabilities
Total equity and liabilities10/49€3.4m€3.5m▲
Equity10/15€1.3m€1.3m▼
Contributions10/11€18,600€18,600=
Reserves13€1.3m€1.2m▼
Distributable reserves133€1.3m€1.2m▼
Amounts payable17/49€2.0m€2.3m▲
Amounts payable after more than one year17€387,636€355,455▼
Financial debts170/4€387,636€355,455▼
Amounts payable within one year42/48€1.6m€1.9m▲
Current portion of amounts payable after more than one year42€31,867€32,181▲
Trade debts44€2,049€15,272▲
Suppliers440/4€2,049€15,272▲
Taxes, remuneration and social security45€99,305€8,047▼
Taxes450/3€98,305€8,047▼
Remuneration and social security454/9€1,000-
Other amounts payable47/48€1.5m€1.8m▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€324,197€157,114▼
Other operating charges640/8€1,544€4,277▲
Gross operating margin9900€160,537€72,364▼
Operating profit (loss)9901-€165,203-€89,027▲
Financial income75/76B€525,090-
Recurring financial income75€525,090-
Financial charges65/66B€4,891€4,252▼
Recurring financial charges65€4,891€4,252▼
Profit (loss) for the period before taxes9903€354,995-€93,278▼
Income taxes67/77€13,636-
Profit (loss) for the period9904€341,359-€93,278▼
Profit (loss) for the period to be appropriated9905€341,359-€93,278▼
Appropriation of the result
Profit (loss) to be appropriated9906€344,055-€93,278▼
Profit (loss) brought forward from the previous period14P€2,696-
Transfer from equity791/2-€93,278
Transfer to equity691/2€344,055-
To other reserves6921€344,055-

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€86,396€127,378€182,393€324,197€157,114▼ 51.5%
Other operating charges640/8€1,243€1,026€1,557€1,544€4,277▲ 177%
Gross operating margin9900€122,181€157,029€206,100€160,537€72,364▼ 54.9%
Operating profit (loss)9901€34,542€28,626€22,150-€165,203-€89,027▲ 46.1%
Financial income75/76B€400,000€748€1,041€525,090--
Recurring financial income75€400,000€748€1,041€525,090--
Financial charges65/66B€19,359€10,139€6,490€4,891€4,252▼ 13.1%
Recurring financial charges65€19,359€10,139€6,490€4,891€4,252▼ 13.1%
Profit (loss) for the period before taxes9903€415,183€19,234€16,702€354,995-€93,278▼ 126%
Income taxes67/77€37,852€5,271€3,779€13,636--
Profit (loss) for the period9904€377,331€13,963€12,923€341,359-€93,278▼ 127%
Profit (loss) for the period to be appropriated9905€377,331€13,963€12,923€341,359-€93,278▼ 127%
Line20212022202320242025Change
Assets
Total assets20/58€1.6m€2.1m€2.7m€3.4m€3.5m▲ 3.8%
Fixed assets21/28€1.1m€1.8m€2.5m€3.3m€3.4m▲ 3.1%
Tangible fixed assets22/27€361,779€1.1m€1.8m€2.6m€2.7m▲ 3.9%
Land and buildings22€361,779€1.1m€1.8m€2.6m€2.6m▲ 0.8%
Plant, machinery and equipment23---€4,994--
Furniture and vehicles24----€84,337-
Financial fixed assets28€717,723€717,723€717,723€717,723€717,723=
Current assets29/58€561,535€298,849€202,561€69,934€97,472▲ 39.4%
Amounts receivable within one year40/41€7,260€14,360€30,250€37,892€20,125▼ 46.9%
Trade receivables40€7,260-€30,250€30,250€15,125▼ 50.0%
Other amounts receivable41-€14,360-€7,642€5,000▼ 34.6%
Cash at bank and in hand54/58€554,275€284,489€172,311€31,278€76,136▲ 143%
Deferred charges and accrued income490/1---€763€1,211▲ 58.6%
Equity and liabilities
Total equity and liabilities10/49€1.6m€2.1m€2.7m€3.4m€3.5m▲ 3.8%
Equity10/15€978,076€992,039€1.0m€1.3m€1.3m▼ 6.9%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Outside capital11€18,600€18,600€18,600---
Other1109/19€18,600€18,600€18,600---
Reserves13€956,780€970,743€983,666€1.3m€1.2m▼ 7.0%
Non-distributable reserves130/1€18,750€18,750€18,750---
Reserves not available under the articles1311€18,750€18,750€18,750---
Distributable reserves133€938,030€951,993€964,916€1.3m€1.2m▼ 7.0%
Profit (loss) carried forward14€2,696€2,696€2,696---
Amounts payable17/49€662,961€1.1m€1.7m€2.0m€2.3m▲ 10.9%
Amounts payable after more than one year17€52,098€471,496€419,503€387,636€355,455▼ 8.3%
Financial debts170/4€52,098€471,496€419,503€387,636€355,455▼ 8.3%
Amounts payable within one year42/48€596,508€653,072€1.3m€1.6m€1.9m▲ 15.5%
Current portion of amounts payable after more than one year42€34,076€66,106€53,686€31,867€32,181▲ 1.0%
Trade debts44€7,637€28,663€231,826€2,049€15,272▲ 646%
Suppliers440/4€7,637€28,663€231,826€2,049€15,272▲ 646%
Taxes, remuneration and social security45€17,854€16,506€25,781€99,305€8,047▼ 91.9%
Taxes450/3€17,854€16,506€24,781€98,305€8,047▼ 91.8%
Remuneration and social security454/9--€1,000€1,000--
Other amounts payable47/48€536,941€541,796€940,616€1.5m€1.8m▲ 22.0%
Accrued charges and deferred income492/3€14,356€179€73---
Line20212022202320242025Change
Profit (loss) for the period9904€377,331€13,963€12,923€341,359-€93,278▼ 127%
+ Depreciation and write-downs630€86,396€127,378€182,393€324,197€157,114▼ 51.5%
Operating cash flow (approximation)€463,727€141,340€195,316€665,556€63,836▼ 90.4%
Investment in fixed assets (approximation)--€865,812-€838,342-€1.2m-€258,360▲ 77.6%
Change in cash--€269,786-€112,177-€141,034€44,858▲ 132%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
01-04
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-09
Financial Weakest financial yearnet -€93,278
Net result drops to -€93,278, the lowest in the series.
30-04
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-04
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
30-09
Financial Equity above €1mEq €1.0m ▲1.3%
6 profitable years in a row build equity to €1.0m.
27-04
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
26-04
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-09
Financial Highest result since 2018net €377,331 ▲465%
Net result €377,331, the highest in the series.
16-03
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-03
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
30-09
Financial Equity above €500,000Eq €538,913 ▲44.7%
2 profitable years in a row build equity to €538,913.
11-03
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
12-03
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
16-03
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Diksmuide · 1 establishment unit since 2004
seat establishment The establishment unit on the map
Ground area
211 m²
Building footprint
211 m²
Volume, LiDAR
1,390 m³
Parcel 32003A0202/00D002, Flanders · tallest building 11.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DELAPHARMA
Grote Markt(D) 4, 8600 DiksmuideFinancial service activities, except insurance and pension funding
since 20042.142.308.445
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
32003A0202/00D002
ProtectedTownscape or village viewGrote Markt met omgevingSource ↗
Flanders 211 m² 1 · 211 m² 11.8 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 30-09-2025 list no shareholders, and no other source names one.

Holdings 1

According to the annual accounts to 30-09-2025 of DELAPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 24,729 companies in sector 64210 we hold annual accounts for 19,773. 12,177 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded13-10-2004
Fiscal year end30-09
Activities, NACEBEL 2025
64210Activities of holding companies
E-invoicing
Reachable via Peppol
Peppol ID 0208:0867801095
Also 9925:BE0867801095
Registered 13-01-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.